5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer (Q28359288)

2

0 references

R Aird

3

0 references

G Knowles

4

0 references

A Bowman

5

0 references

L Wall

6

0 references

C McLean

British Journal of Cancer

7

0 references

language of work or name

English

0 references

publication date

2 March 2001

0 references

published in

0 references

volume

84

0 references

issue

5

0 references

page(s)

600-3

0 references

cites work

Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363784

Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British population

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363784

Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363784

5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363784

Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363784

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363784

Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infus

27 November 2018

1 reference

12 December 2020

Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients

1 reference

12 December 2020

Marked fluctuations in drug plasma concentrations caused by use of portable pumps for fluorouracil continuous infusion

1 reference

12 December 2020

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients

1 reference

12 December 2020

Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy

1 reference

12 December 2020

Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer

1 reference

12 December 2020

Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without int

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1664

1 reference

Dimensions Publication ID

4425232

1025651270

0 references

Fatcat ID

release_lgwizzp4ybdk7pimhdrfblpef4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lgwizzp4ybdk7pimhdrfblpef4

24 November 2022

mapped directly with Wikidata item

4425232

1 reference

1 reference

1 reference